RFA 5 – Funding Announcement
As part of ACT’s goal to expand Canada’s participation in international trials, they recently hosted a fifth request for applications to bring high impact randomized controlled trials to Canada that are initiated and are led by a non-Canadian country.

We are pleased to announce that CNTN Scientific Operations Committee co-lead Dr. David Collister had a successfully RFA 5 application endorsed by CNTN. His teams application on the Better Evidence And Translation for Calciphylaxis (BEAT-Calci) global platform trial, with Dr. Meg Jardine from the University of Sydney, was ranked as one of the top ten applications awarded to receive ACT funding for this call for proposals .

RFA 6 – Canadian Biotech Call for Proposals
Another key objective of the ACT Consortium is to facilitate collaboration between Canadian biotechnology groups and clinical trialists. Since most biotechnologies require RCTs demonstrating efficacy and safety to obtain regulatory approvals in Canada, the objective of this RFA is to fund trials evaluating products from Canadian-controlled biotechnology companies in partnership with ACT Network clinical trialists.

Applicants can request up to $400,000 (CAN) in funding to facilitate phase 2, pilot, or Vanguard trials.  Trials that assess safety, recruitment potential, and feasibility are also welcome provided they are an RCT.

Eligibility:

For an application to be eligible, it must fulfill the following criteria.

  • Trial must evaluate a biotechnology from a Canadian-controlled biotechnology company.
  • The proposal must be an RCT and not a product validation observational study.
  • The proposed budget must be CIHR eligible.

 Deadline: The deadline to apply is Sunday January 5th, 2025 at 11:59 pm ET

Application Process:

The application portal can be found here: https://redc.phri.ca/redcap/surveys/?s=LDWA7RLTFJWLNNEM

If you have any questions about the applications process, please reach out to us at: ACT.Canada@PHRI.ca

Should you have any questions or require assistance, please reach out by December 20, 2024 to ensure a prompt response. Queries received after this date may not garner a response.